These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2568040)

  • 21. [The property of filamentous hemagglutinin of Bordetella pertussis].
    Chow MP; Lin CK; Lin JS; Chau WK; Ho CH; Chen SY; Lee SH; Yung CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Nov; 24(4):331-8. PubMed ID: 1845342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Location of the three major agglutinogens of Bordetella pertussis by immuno-electronmicroscopy.
    Preston NW; Zorgani AA; Carter EJ
    J Med Microbiol; 1990 May; 32(1):63-8. PubMed ID: 1971311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple, efficient purification of filamentous hemagglutinin and pertussis toxin from Bordetella pertussis by hydrophobic and affinity interaction.
    Skelton SK; Wong KH
    J Clin Microbiol; 1990 May; 28(5):1062-5. PubMed ID: 2351723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agglutinogens and fimbriae of Bordetella pertussis.
    Ashworth LA; Robinson A; Funnell S; Gorringe AR; Irons LI; Seabrook RN
    Tokai J Exp Clin Med; 1988; 13 Suppl():203-10. PubMed ID: 2908520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-envelope proteins of Bordetella pertussis.
    Parton R; Wardlaw AC
    J Med Microbiol; 1975 Feb; 8(1):47-57. PubMed ID: 165297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Polyacrylamide gel disc electrophoretic study of laboratory and freshly isolated strains of Bordetella pertussis and Bordetella parapertussis].
    Samsonova VS; Mamaeva EA; Kondrat'eva AM
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Oct; (10):21-4. PubMed ID: 6277109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities].
    Atakan Ablay P; Ozcengiz E
    Mikrobiyol Bul; 2007 Jan; 41(1):11-20. PubMed ID: 17427548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.
    Barkoff AM; Mertsola J; Guillot S; Guiso N; Berbers G; He Q
    Clin Vaccine Immunol; 2012 Oct; 19(10):1703-4. PubMed ID: 22914363
    [No Abstract]   [Full Text] [Related]  

  • 30. [An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MH; Britsina MV; Shmeleva EI; Mertsalova NU; Ermolova EI; Sukhinova EE; Bulk VF; Sirotinskiĭ AV; Poluiianova AG; Sviridov VV; Vartanian IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):67-70. PubMed ID: 9304334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Bordetella pertussis suspensions by ELISA and flow cytometry.
    Jiskoot W; Westdijk J; Reubsaet CH; Beuvery EC
    Adv Exp Med Biol; 1996; 397():153-7. PubMed ID: 8718594
    [No Abstract]   [Full Text] [Related]  

  • 32. [The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].
    Shmeleva EI; Mertsalova NU; Sukhinova EV; Kirillova GA; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Britsina MV; Ermolova EV; Zakharova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):47-50. PubMed ID: 9245141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release and purification of fimbriae from Bordetella pertussis.
    Irons LI; Ashworth LA; Robinson A
    Dev Biol Stand; 1985; 61():153-63. PubMed ID: 2872101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine.
    Petersen JW; Andersen P; Ibsen PH; Capiau C; Wachmann CH; Hasløv K; Heron I
    Vaccine; 1993; 11(4):463-72. PubMed ID: 8470432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A; Hawkins DC
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.
    Tuomanen E; Weiss A; Rich R; Zak F; Zak O
    Dev Biol Stand; 1985; 61():197-204. PubMed ID: 2872105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphology of cells and hemagglutinogens of Bordetella species: resolution of substructural units in fimbriae of Bordetella pertussis.
    Blom J; Hansen GA; Poulsen FM
    Infect Immun; 1983 Oct; 42(1):308-17. PubMed ID: 6137457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.